Wang Dajia,Zhang Zhibo,Bai Yuzuo.Unplanned readmissions of infants after pull-through for Hirschsprung disease[J].Journal of Clinical Pediatric Surgery,2021,20(03):217-221.[doi:10.12260/lcxewkzz.2021.03.004]
先天性巨结肠根治术后非计划再入院原因分析
- Title:
- Unplanned readmissions of infants after pull-through for Hirschsprung disease
- 关键词:
- 先天性巨结肠/外科学; 病人再入院; 再手术; 小肠结肠炎; 婴儿
- 分类号:
- R726.1;R574;R516.1
- 摘要:
- 目的 总结分析婴儿期行先天性巨结肠根治手术患者术后非计划再入院的原因。方法 回顾性分析中国医科大学附属盛京医院新生儿外科2011年10月至2020年9月接受手术治疗的1至6月龄先天性巨结肠患者的临床资料，包括病理分型、手术方式、再入院原因、再入院时间等。结果 资料完整的先天性巨结肠患者共326例，男271例（83.1%），女55例（16.9%），手术时平均月龄（2.53±1.32）个月。其中51例出院后非计划再次入院，再入院率15.64%，再入院总次数为64次，其中10例多次入院。出院后再入院时间分布情况：1个月内再入院28例（54.9%）；1个月至1年再入院12例（23.5%），1至3年再入院11例（21.57%）。再入院主要原因分布情况：巨结肠术后小肠炎56例次（87.5%）、肠梗阻6例次（9.4%），电解质紊乱2例次（3.1%）。其中2例（0.6%）行手术治疗，1例术后3个月因肠梗阻行肠粘连松解术，1例术后3年因巨结肠复发行腹腔镜下结肠次全切除及结肠翻转术。按入院时间划分，2017年及之前手术248例保留肌鞘较长，再入院45例（18.1%）；2018年至2020年78例保留短肌鞘，再入院6例（7.7%）；差异具有统计学意义（χ2=4.913，P=0.027）。结论 小肠结肠炎和肠梗阻是导致巨结肠手术后再次入院的主要原因，再次入院时间大多在术后1个月内。术后增加随访频率可能会减少术后早期再入院的发生。此外，术中保留肌鞘较短可减少术后小肠结肠炎和肠梗阻的发生，降低再入院率。
- Abstract:
- Objective To analyze unplanned readmissions of infants after pull-through for Hirschsprung disease (HSCR).Methods This retrospective cohort study was performed for 326 infants undergoing operations for Hirschsprung disease between October,2011 and September,2020.Clinical data,pathological type,approaches,readmission causes and readmission time were statistically analyzed. Results A total of 51 infants (15.6%) had an unplanned hospitalization after discharge.There were 271 boys and 55 girls with a mean operative age of (2.53±1.32) months.Fifty-one cases (15.6%) were readmitted for 64 times and 10 (19.6%) admitted multiple times.Time to readmission after discharge was as follows:28 infants (54.9%) were readmitted within 1 month after discharge,12 (23.5%) from 1 month to 1 year and 11 (21.6%) from 1 to 3 years.Readmission causes included enterocolitis infection (n=56,87.5%),intestinal obstruction (n=6,9.4%) and electrolyte disturbance (n=2,3.1%).Two patients (0.6%) underwent unplanned secondary surgery of lysis of intestinal adhesion (n=1) and laparoscopic subtotal colon resection and rotation of right colon (n=1) at Year 3 after pull-through.Prior to 2017,45/248 patients (18.1%) were admitted with longer muscle sheaths.From 2018 to 2020,6/78 patients (7.7%) returned to the hospital with shorter muscular sheaths.There was statistically significant difference (χ2=4.913,P=0.027). Conclusion Enterocolitis and intestinal obstruction are the major causes of readmission after pull-through in HSCR infants.Most readmissions occur within 1 month of surgery.Frequent follow-ups may reduce the incidence of early postoperative readmission.A shorter muscle sheath may reduce the postoperative incidence of enterocolitis and intestinal obstruction and lower the readmission rate.
参考文献/References:
1 Kapur RP.Practical pathology and genetics of Hirschsprung’s disease[J].Semin Pediatr Surg,2009,18(4):212-223.DOI:10.1053/j.sempedsurg.2009.07.003.
2 Swenson O.Hirschsprung’s disease:a review[J].Pediatrics,2002,109(5):914-918.DOI:10.1542/peds.109.5.914.
3 De la Torre L,Ortega A.Transanal versus open endorectal pull-through for Hirschsprung’s disease[J].J Pediatr Surg,2000,35(11):1630-1632.DOI:10.1053/jpsu.2000.18338.
4 谢崇,潘伟康,高亚,等.我国大陆地区先天性巨结肠症诊疗情况调查[J].中华小儿外科杂志,2018,39(6):411-418.DOI:10.3760/cma.j.issn.0253-3006.2018.06.003. Xie C,Pan WK,Gao Y,et al.Surveying of management status of Hirschsprung’s disease in mainland China[J].Chin J Pediatr Surg,2018,9(6):411-418.DOI:10.3760/cma.j.issn.0253-3006.2018.06.003.
5 Kyrklund K,Sloots CEJ,de Blaauw I,et al.ERNICA guidelines for the management of rectosigmoid Hirschsprung’s disease[J].Orphanet J Rare Dis,2020,15(1):164.DOI:10.1186/s13023-020-01362-3.
6 Nataraja RM,Ferguson P,King S,et al.Management of Hirschsprung disease in Australia and New Zealand:a survey of the Australian and New Zealand Association of Paediatric Surgeons (ANZAPS)[J].Pediatr Surg Int,2019,35(4):419-423.DOI:10.1007/s00383-018-04432-7.
7 Langer JC,Rollins MD,Levitt M,et al.American Pediatric Surgical Association Hirschsprung Disease Interest Group.Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease[J].Pediatr Surg Int,2017,33(5):523-526.DOI:10.1007/s00383-017-4066-7.
8 Gosain A,Frykman PK,Cowles RA,et al.American Pediatric Surgical Association Hirschsprung Disease Interest Group:Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis[J].Pediatr Surg Int,2017,33(5):517-521.DOI:10.1007/s00383-017-4065-8.
9 Quiroz HJ,Perez EA,Franklin KN,et al.Pull-through procedure in children with Hirschsprung disease:A nationwide analysis on postoperative outcomes[J].J Pediatr Surg,2020,55(5):899-903.DOI:10.1016/j.jpedsurg.2020.01.038.
10 施诚仁.再谈先天性巨结肠小肠结肠炎的防治[J].临床小儿外科杂志,2019,18(5):348-351.DOI:10.3969/j.issn.1671-6353.2019.05.002. Shi CR.Re-discussion on prevention and treatment of congenital megacolon enterocolitis[J].J Clin Ped Sur,2019,18(5):348-351.DOI:10.3969/j.issn.1671-6353.2019.05.002.
11 Coran AG.Pediatric Surgery,7th Edition[M].Mosby,2012.Chaper 101,1265-1278.
12 Neuvonen MI,Kyrklund K,Rintala RJ,et al.Bowel function and quality of life after transanal endorectal pull-through for Hirschsprung disease:controlled outcomes up to adulthood[J].Ann Surg,2017,265(3):622-629.DOI:10.1097/SLA.0000000000001695.
13 Pakarinen M.Perioperative complications of transanal pull-through surgery for Hirschsprung’s disease[J].Eur J Pediatr Surg,2018,28(2):152-155.DOI:10.1055/s-0038-1632393.
14 Tam PKH,Chung PHY,St Peter SD,et al.Advances in paediatric gastroenterology[J].Lancet,2017,390(10099):1072-1082.DOI:10.1016/S0140-6736(17)32284-5.
15 Louis-Borrione C,Faure A,Garnier S,et al.Neurostimulation-guided anal intrasphincteric botulinum toxin injection in children with Hirschsprung disease[J].J Pediatr Gastroenterol Nutr,2019,68(4):527-532.DOI:10.1097/MPG.0000000000002204.
16 高亚.先天性巨结肠症的诊断与治疗挑战与机遇[J].中华小儿外科杂志,2018,39(6):401-403.DOI:10.3760/cma.j.issn.0253-3006.2018.06.001. Gao Y.Diagnosis and treatment of Hirschsprung’s disease:challenges and opportunities[J].Chin J Pediatr Surg,2018,39(6):401-403.DOI:10.3760/cma.j.issn.0253-3006.2018.06.001.
17 Lefcort F.Development of the autonomic nervous system:clinical implications[J].Semin Neurol,2020,40(5):473-484.DOI:10.1055/s-0040-1713926.
相似文献/References:
[1]曾纪晓,徐晓钢.先天性巨结肠诊疗规范化的再思考[J].临床小儿外科杂志,2021,20(03):201.[doi:10.12260/lcxewkzz.2021.03.001]
Zeng Jixiao,Xu Xiaogang.Some focal issues of standardizing the diagnosis and treatment of Hirschsprung’s disease[J].Journal of Clinical Pediatric Surgery,2021,20(03):201.[doi:10.12260/lcxewkzz.2021.03.001]
[2]李颀,张震,李龙.先天性巨结肠再次手术的技术和思考[J].临床小儿外科杂志,2021,20(03):208.[doi:10.12260/lcxewkzz.2021.03.002]
Li Qi,Zhang Zhen,Li Long.Techniques and considerations of re-operations for Hirschsprung’s disease[J].Journal of Clinical Pediatric Surgery,2021,20(03):208.[doi:10.12260/lcxewkzz.2021.03.002]
[3]谢华,唐维兵.规范、统一先天性巨结肠分型的建议[J].临床小儿外科杂志,2021,20(03):212.[doi:10.12260/lcxewkzz.2021.03.003]
Xie Hua,Tang Weibing.Unifying the classification of Hirschsprung’s disease[J].Journal of Clinical Pediatric Surgery,2021,20(03):212.[doi:10.12260/lcxewkzz.2021.03.003]
[4]兰梦龙,曾纪晓,徐晓钢,等.先天性巨结肠术后便秘复发再手术19例[J].临床小儿外科杂志,2021,20(03):230.[doi:10.12260/lcxewkzz.2021.03.006]
Lan Menglong,Zeng Jixiao,Xu Xiaogang,et al.Redo pull-through for Hirschsprung’s disease with recurrent postoperative constipation[J].Journal of Clinical Pediatric Surgery,2021,20(03):230.[doi:10.12260/lcxewkzz.2021.03.006]
[5]曾纪晓,徐晓钢,刘斐,等.经脐单孔腹腔镜辅助下Swenson-like巨结肠根治术38例[J].临床小儿外科杂志,2021,20(09):848.[doi:10.12260/lcxewkzz.2021.09.009]
Zeng Jixiao,Xu Xiaogang,Liu Fei,et al.Efficacies of transumbilical laparoendoscopic single-port surgery for Hirschsprung disease in children,a report of 38 cases[J].Journal of Clinical Pediatric Surgery,2021,20(03):848.[doi:10.12260/lcxewkzz.2021.09.009]
备注/Memo
收稿日期:2021-01-15。
基金项目:辽宁省重点研发计划联合计划（编号：2020JH2/10300131）；辽宁省兴辽英才计划（编号：XLYC1908008）
通讯作者:王大佳,Email:wangdj@sj-hospital.org